SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR [Internet]. 2025 Jan. 11 [cited 2026 Jul. 28];3(1):522-31. Available from: https://medicalsciencereview.com/index.php/Journal/article/view/403